BRANFORD, Conn., Aug. 22 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. (Nasdaq: CASM - News), a medical device company focused on innovative non-invasive vital signs monitoring, announced today that Andrew Kersey, Chief Operating Officer and Jeffery Baird, Chief Financial Officer will be presenting an overview of the Company at the Roth Capital Partners Leaders in Small and Micro-Cap Markets Conference in New York City, Thursday, September 7, 2006 at 2:30 pm Eastern Time. The conference is being held at the Westin New York in Times Square, New York City.
Mr. Kersey and Mr. Baird will provide a brief corporate overview and discuss the Company’s Cerebral Oximeter, FORE-SIGHT(TM), which is planned for launch by the end of 2006. The FORE-SIGHT Cerebral Oximeter measures absolute cerebral tissue oxygen saturation and provides new information that allows clinicians to monitor and quickly respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.
The presentation will also be broadcast live over the Internet, and will be accessible until October 7 on the Company’s website at http://www.casmed.com. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast.
About CAS Medical Systems, Inc.
Founded in 1984, CAS Medical Systems, Inc. (CASMED(TM)) is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, blood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
For more information contact: ir@casmed.com
Investors Media Financial Dynamics Financial Dynamics John Capodanno Robert Stanislaro 212-850-5705 212-850-5657 jcapodanno@fd-us.com rstanislaro@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company’s Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward- looking statements, whether as a result of future events, new information or otherwise.
Source: CAS Medical Systems, Inc.
